EUROPEAN REGIONAL DEVELOPMENT FUND

Mahana Therapeutics Selected for Prestigious Digitalhealth.London Accelerator Program

Retrieved on: 
Tuesday, January 18, 2022

Mahana Therapeutics , a leading developer of prescription digital therapeutics designed to empower people living with chronic health conditions, today announced that Mahana has been selected for the DigitalHealth.Londons Accelerator programme .

Key Points: 
  • Mahana Therapeutics , a leading developer of prescription digital therapeutics designed to empower people living with chronic health conditions, today announced that Mahana has been selected for the DigitalHealth.Londons Accelerator programme .
  • The program will help Mahana Therapeutics better engage with the NHS to accelerate adoption of Mahana IBS in clinical practice.
  • We are excited to join this prestigious program to accelerate adoption of and experience with Mahana IBS within the NHS.
  • Mahana Therapeutics is a leading developer of effective prescription digital therapeutics that are designed to empower patients with chronic conditions to live fuller lives.